Sustaining platelet counts in chronic ITP

The Lancet

Volumn 377, Issue 9763, 2011, Pages 358-360

  Nurden, Alan T ^a  

^a Ctr Geriatrie Ctr Hosp Univ B   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ELTROMBOPAG; ROMIPLOSTIM;

DIARRHEA; DRUG TOLERABILITY; HEADACHE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LONG TERM CARE; NAUSEA; NOTE; PRIORITY JOURNAL; SIDE EFFECT; SPLENECTOMY; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING;

EID: 79251620633     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61090-2     Document Type: Note

References (10)

1. AT Nurden, JF Viallard, P Nurden New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura Lancet 373 2009 1562 1569
2. A Metjian, CS Abrams New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor stimulating agents Biologics 3 2009 499 513
3. DJ Kuter, JB Bussel, RM Lyons Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial Lancet 371 2008 395 403
4. JB Bussel, D Provan, T Shamsi Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial Lancet 373 2009 641 648
5. G Cheng, MN Saleh, C Marcher Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study Lancet 2010 10.1016/S0140-6736(10)60959-2 published online Aug 24.
6. JB Bussel, DJ Kuter, V Pullarkat, RM Lyons, M Guo, JL Nichol Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP Blood 113 2009 2161 2171
7. TB Gernsheimer, JN George, LM Aledort Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP) J Thromb Haemost 8 2010 1372 1382
8. J Bussel, M Saleh, O Meyer Results of bone marrow examinations in patients with chronic idiopathic (immune) thrombocytopenic purpura treated with eltrombopag for more than one year June 10-13, 2010 15th Congress of the European Haematology Association Barcelona, Spain 0604 (abstr).
9. D Provan, R Stasi, AC Newland International consensus report on the investigation and management of primary immune thrombocytopenia Blood 115 2010 168 186
10. H Kantarjian, P Fenaux, MA Sekeres Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia J Clin Oncol 28 2010 437 444